Details for New Drug Application (NDA): 050796
✉ Email this page to a colleague
NDA 050796 describes CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER, which is a drug marketed by B Braun and is included in one NDA. It is available from one supplier. Additional details are available on the CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER profile page.
The generic ingredient in CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER is ceftriaxone sodium. There are twenty-six drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the ceftriaxone sodium profile page.
The generic ingredient in CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER is ceftriaxone sodium. There are twenty-six drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the ceftriaxone sodium profile page.
Summary for 050796
| Tradename: | CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER |
| Applicant: | B Braun |
| Ingredient: | ceftriaxone sodium |
| Patents: | 0 |
Suppliers and Packaging for NDA: 050796
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | ceftriaxone sodium | INJECTABLE;INJECTION | 050796 | NDA | B. Braun Medical Inc. | 0264-3153 | 0264-3153-11 | 24 CONTAINER in 1 CASE (0264-3153-11) / 50 mL in 1 CONTAINER |
| CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER | ceftriaxone sodium | INJECTABLE;INJECTION | 050796 | NDA | B. Braun Medical Inc. | 0264-3155 | 0264-3155-11 | 24 CONTAINER in 1 CASE (0264-3155-11) / 50 mL in 1 CONTAINER |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
| Approval Date: | Apr 20, 2005 | TE: | AP | RLD: | Yes | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL | ||||
| Approval Date: | Apr 20, 2005 | TE: | AP | RLD: | Yes | ||||
Complete Access Available with Subscription
